These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32366680)

  • 1. Longitudinal Analysis of Serum Cytokine Levels and Gut Microbial Abundance Links IL-17/IL-22 With
    Zhou X; Johnson JS; Spakowicz D; Zhou W; Zhou Y; Sodergren E; Snyder M; Weinstock GM
    Diabetes; 2020 Aug; 69(8):1833-1842. PubMed ID: 32366680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function.
    Zhao H; Shang L; Zhang Y; Liang Z; Wang N; Zhang Q; Gao C; Luo J
    Front Immunol; 2024; 15():1344963. PubMed ID: 38482003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
    World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant intestinal microbiota in individuals with prediabetes.
    Allin KH; Tremaroli V; Caesar R; Jensen BAH; Damgaard MTF; Bahl MI; Licht TR; Hansen TH; Nielsen T; Dantoft TM; Linneberg A; Jørgensen T; Vestergaard H; Kristiansen K; Franks PW; ; Hansen T; Bäckhed F; Pedersen O
    Diabetologia; 2018 Apr; 61(4):810-820. PubMed ID: 29379988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
    Pinna NK; Anjana RM; Saxena S; Dutta A; Gnanaprakash V; Rameshkumar G; Aswath S; Raghavan S; Rani CSS; Radha V; Balasubramanyam M; Pant A; Nielsen T; Jørgensen T; Færch K; Kashani A; Silva MCA; Vestergaard H; Hansen TH; Hansen T; Arumugam M; Nair GB; Das B; Pedersen O; Mohan V; Mande SS
    Genome Med; 2021 Mar; 13(1):36. PubMed ID: 33658065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of the relation between gut microbiome, metabolic disease and hypertension].
    Barna I; Nyúl D; Szentes T; Schwab R
    Orv Hetil; 2018 Mar; 159(9):346-351. PubMed ID: 29480046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decreased abundance of clostridia characterizes the gut microbiota in eosinophilic esophagitis.
    Kashyap PC; Johnson S; Geno DM; Lekatz HR; Lavey C; Alexander JA; Chen J; Katzka DA
    Physiol Rep; 2019 Oct; 7(20):e14261. PubMed ID: 31650712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
    Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
    Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and health.
    Kc D; Sumner R; Lippmann S
    Postgrad Med; 2020 Apr; 132(3):274. PubMed ID: 31566046
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal multi-omics of host-microbe dynamics in prediabetes.
    Zhou W; Sailani MR; Contrepois K; Zhou Y; Ahadi S; Leopold SR; Zhang MJ; Rao V; Avina M; Mishra T; Johnson J; Lee-McMullen B; Chen S; Metwally AA; Tran TDB; Nguyen H; Zhou X; Albright B; Hong BY; Petersen L; Bautista E; Hanson B; Chen L; Spakowicz D; Bahmani A; Salins D; Leopold B; Ashland M; Dagan-Rosenfeld O; Rego S; Limcaoco P; Colbert E; Allister C; Perelman D; Craig C; Wei E; Chaib H; Hornburg D; Dunn J; Liang L; Rose SMS; Kukurba K; Piening B; Rost H; Tse D; McLaughlin T; Sodergren E; Weinstock GM; Snyder M
    Nature; 2019 May; 569(7758):663-671. PubMed ID: 31142858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Deficits in Gut Microbiome of Young and Middle-Aged Adults with Prediabetes Apparent in Metabolizing Bioactive (Poly)phenols.
    Zhang X; Zhao A; Sandhu AK; Edirisinghe I; Burton-Freeman BM
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33238618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye.
    Jayasudha R; Chakravarthy SK; Prashanthi GS; Sharma S; Garg P; Murthy SI; Shivaji S
    J Biosci; 2018 Dec; 43(5):835-856. PubMed ID: 30541945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
    Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
    Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-life gut microbiome composition and milk allergy resolution.
    Bunyavanich S; Shen N; Grishin A; Wood R; Burks W; Dawson P; Jones SM; Leung DYM; Sampson H; Sicherer S; Clemente JC
    J Allergy Clin Immunol; 2016 Oct; 138(4):1122-1130. PubMed ID: 27292825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis.
    Jiao N; Baker SS; Nugent CA; Tsompana M; Cai L; Wang Y; Buck MJ; Genco RJ; Baker RD; Zhu R; Zhu L
    Physiol Genomics; 2018 Apr; 50(4):244-254. PubMed ID: 29373083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
    Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
    Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.